KAP1 is relevant to the mode of action of anti‐cancer 5‐AZA‐based drugs since KAP1 and cytosine methylation repress some of the same ERVs and suppress MAVS‐dependent RNA sensing (see Fig 6 for a model). Here, MAVS is linked to cancer.